Free Trial
OTCMKTS:HLTRF

HLS Therapeutics (HLTRF) Stock Price, News & Analysis

HLS Therapeutics logo
$2.64 +0.04 (+1.54%)
As of 11:59 AM Eastern

About HLS Therapeutics Stock (OTCMKTS:HLTRF)

Advanced

Key Stats

Today's Range
$2.64
▼
$2.71
50-Day Range
$2.60
▼
$3.25
52-Week Range
$2.46
▼
$3.45
Volume
1,700 shs
Average Volume
1,527 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Strong Buy

Company Overview

HLS Therapeutics Inc. is a specialty pharmaceutical company focused on acquiring, licensing, developing and commercializing prescription medicines. Rather than primarily discovering new drugs, the company generally builds value by obtaining rights to established or differentiated pharmaceutical products and supporting their regulatory approval, market access and commercial distribution.

The company’s activities have centered on specialty-care and hospital-related therapies, including products for central nervous system and cardiovascular conditions. Its portfolio has included Clozaril (clozapine), an antipsychotic medicine used in the treatment of schizophrenia, as well as other prescription products commercialized through regional licensing and distribution arrangements.

HLS Therapeutics serves pharmaceutical markets in Canada and the United States, with operations and product rights varying by therapy and geography. The company’s business model emphasizes focused commercial infrastructure, partnerships with pharmaceutical manufacturers and the expansion of access to specialized medicines in the markets it serves.

AI Generated. May Contain Errors.

Receive HLTRF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for HLS Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

HLTRF Stock News Headlines

HLS Therapeutics Q3 Net Loss Narrows
My $247 scanner for $7
Bill Poulos is cutting the price of his $247 Instant Scanner to $7 for Black Friday. It's a one-time payment that covers a full year, with no subscription and no re-bills. Every night after the close, the scanner screens nearly a thousand of America's biggest stocks. It returns a short list of qualifying setups with the exact buy price next to each one. There's nothing to install. If you decide it's not for you, you get the $7 back and keep the scanner for the year.tc pixel
HLS Therapeutics : Third Quarter 2026 Presentation
HLS Therapeutics Announces Board of Directors Changes
See More Headlines

HLTRF Stock Analysis - Frequently Asked Questions

HLS Therapeutics' stock was trading at $3.43 at the beginning of 2026. Since then, HLTRF stock has decreased by 23.0% and is now trading at $2.64.

Shares of HLTRF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Pharmaceuticals
Sub-Industry
Pharmaceuticals
Current Symbol
OTCMKTS:HLTRF
CIK
N/A
Fax
N/A
Employees
85
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A
Forget Nvidia, Meta, and Google. Here's The New Magnificent Seven. Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (OTCMKTS:HLTRF) was last updated on 11/16/2026 by MarketBeat.com Staff.
From Our Partners